SEC Form 4 · accession 0001213900-15-009092
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 12, 2014
Accepted (ET)
Nov 25, 2015 · 11:57 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 12, 2014 | J | 2,402,299 | $0.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person distributed 2,402,299 shares of common stock of the Issuer to its 25 individual shareholders on or about June 12, 2014